Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|February 1, 1997
Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestionK Laine, K T Kivistö, P Ojala-Karlsson, et al.
Biotechniques|January 28, 2003
Electrophoretic signal comparison applied to mRNA differential display analysisT Aittokallio, T Pahikkala, P Ojala, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitorsR Laaksonen, J P Ojala, M J Tikkanen, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 19, 2000
Distribution of group II phospholipase A2 protein and mRNA in rat tissuesK M Nyman, P Ojala, V J Laine, et al.
Life Sciences|January 1, 1991
Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteersM Scheinin, S Karhuvaara, P Ojala-Karlsson, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine dispositionS Sundberg, M Scheinin, P Ojala-Karlsson, et al.
Atherosclerosis|February 10, 1997
Screening of the 3' two-thirds of the coding area of the apo B gene in Finnish hypercholesterolemic patients report of six new genetic variantsM Ilmonen, T Ebeling, J Viikari, et al.
Atherosclerosis|May 1, 1990
Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-upJ P Ojala, E Helve, K Karjalainen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression systemJ P Kukkonen, J Näsman, P Ojala, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecaponeS Sundberg, M Scheinin, P Ojala-Karlsson, et al.
Pageof 3